comparemela.com


Published May 4, 2021, 2:51 PM
The Food and Drug Administration (FDA) on Tuesday, May 4, said it cannot assure for the safety and quality of the products used under the condition of a Compassionate Special Permit (CSP) as it did not undergo evaluation by the agency.
Food and Drug Administration (FDA) Director General Eric Domingo
FDA Director General Eric Domingo said an unregistered drug, medical device, or food product used under the condition of a CSP does not undergo evaluation by the FDA.
“So when we give a compassionate special permit it is very clear that we have no assurance of safety, efficacy, and quality because it did not undergo evaluation with the FDA,” Domingo said in virtual press briefing.

Related Keywords

Malaca ,Pangasinan ,Philippines ,Manila ,Eric Domingo ,Harry Roque ,Drug Administration ,Compassionate Special Permit ,Director General Eric ,General Eric Domingo ,Chinese Made Sinopharm ,Manila Bulletin ,பங்கசினன் ,பிலிப்பைன்ஸ் ,மணிலா ,எரிக் டொமிஂகொ ,ஹாரி ரோக் ,இரக்கமுள்ள சிறப்பு அனுமதி ,இயக்குனர் ஜநரல் எரிக் ,ஜநரல் எரிக் டொமிஂகொ ,மணிலா புல்லட்டின் ,

© 2024 Vimarsana

comparemela.com © 2020. All Rights Reserved.